$12.89
0[0.00%]
At close: Apr 23
$12.89
0[0.00%]
PreMarket: 4:02PM EDT
Entrada Therapeutics
(NASDAQ:TRDA)Entrada Therapeutics Stock (NASDAQ:TRDA), Quotes and News Summary
Entrada Therapeutics Stock (NASDAQ: TRDA) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 75.884K |
| Day Range | - - - |
| 52 Wk Range | 10.620 - 18.440 |
| Market Cap | $433.118M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 48 |
| Short Interest | 9.05% |
| Days to Cover | 29.93 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Entrada Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of p...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Entrada Therapeutics (TRDA) stock?
You can purchase shares of Entrada Therapeutics (NASDAQ: TRDA) through any online brokerage.
Who are Entrada Therapeutics's (TRDA) competitors?
Other companies in Entrada Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Replimune Group (NASDAQ:REPL).
What is the target price for Entrada Therapeutics (TRDA) stock?
The latest price target for Entrada Therapeutics (NASDAQ: TRDA) was reported by HC Wainwright & Co. on Monday, March 18, 2024. The analyst firm set a price target for 20.00 expecting TRDA to rise to within 12 months (a possible 55.16% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Entrada Therapeutics (TRDA)?
The stock price for Entrada Therapeutics (NASDAQ: TRDA) is $12.89 last updated April 23, 2024 at 4:02 PM EDT.
Does Entrada Therapeutics (TRDA) pay a dividend?
There are no upcoming dividends for Entrada Therapeutics.
When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?
Entrada Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
Is Entrada Therapeutics (TRDA) going to split?
There is no upcoming split for Entrada Therapeutics.
What sector and industry does Entrada Therapeutics (TRDA) operate in?
Entrada Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.